13 ADDITIONS - 1 RETRAIT



Similar documents
AMYVID FORBETAPIR (F 18) Q.S. ELI LILLY NEDERLAND BV New AS ARZERRA OFATUMUMAB MG/ML GLAXO GROUP LTD Conditional auth, PASS

NEISSERIA MENINGITIDES B, RECOMBINANT, COMPONENT, ADSORBED Q.S.

NEISSERIA MENINGITIDES B, RECOMBINANT, COMPONENT, ADSORBED Q.S.

NEISSERIA MENINGITIDES B, RECOMBINANT, COMPONENT, ADSORBED Q.S.

NEISSERIA MENINGITIDES B, RECOMBINANT, COMPONENT, ADSORBED Q.S.

NEISSERIA MENINGITIDES B, RECOMBINANT, COMPONENT, ADSORBED Q.S.

comparison of access and reimbursement environments A report benchmarking Australia s access to new medicines Edition 1

Applications for new human medicines under evaluation by the Committee for Medicinal Products for Human Use

NEW DRUG APPROVALS IN ICH COUNTRIES FOCUS ON 2013

PATIENT ASSISTANCE PROGRAMS

Specialty Pipeline Update

ATC/DDD Classification

Biggest Launches 2014

Manufacturer of drug substance

Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct

Special Authorization

WORLD PREVIEW 2014, OUTLOOK TO 2020

Lists of medicinal products for rare diseases in Europe*

Liste des médicaments pour les maladies rares en Europe*

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Handling, Segregation and Disposal of Cytostatic and Cytotoxic Waste

1 ST QUARTER 2015 UPDATE CHANGES TO THE HIGHMARK DRUG FORMULARIES

Clinical trial research agreement Agreed schedule 4 or 7 clause amendments

Drugs Not Approved By the Scottish Medicines Consortium

Medical School for Actuaries. June 12, Baltimore, Maryland

6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality

EU Clinical Trials Register

List of nationally authorised medicinal products

Applications for new human medicines under evaluation by the Committee for Medicinal Products for Human Use

Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)

CHEM-E4140 Selectivity 12. Pharma Business

Annual Press Conference Business Year 2011

Monitoring Usage in Wales of Medicines Appraised by NICE and AWMSG

Human Tubal Fluid (HTF) Media & Modifi ed Human Tubal Fluid (mhtf) Medium with Gentamicin

Guide. Astellas Pharma US, Inc. XTANDI Access Services SM 2015 NCCN Virtual Reimbursement Resource Room. NCCN.org/reimbursement

Listados de medicamentos para enfermedades raras en Europa*

New Drug Approvals. Elizabeth A. Shlom, PharmD, BCPS President, NYSCHP SVP/Director, Clinical Pharmacy Services GNYHA Services, Inc.

Pharma working capital performance highly variable

ehealthinsight Series: Online Patient Recruitment Strategies

KEEPING CLINICAL TRIALS IN AUSTRALIA

EvaluatePharma World Preview 2015, Outlook to 2020

DRUGS BILLED UNDER MISCELLANEOUS CODES J3490, J3590, J9999 OR C9399 COVERAGE INFORMATION

Stakeholder Perspectives: Mild Cognitive Impairment and Dementia

Metastatic Breast Cancer - Pipeline Review, Q1 2011

BOLT Hem/Onc Thought Leader Panel #38 Cancer Immunotherapy

Commercial Insight Osteoarthritis and Rheumatoid Arthritis

Preferred Drug List Updates Effective: Jan. 1, 2016

The power of creativity Pharmaceutical Branding 2012

Malignant Mesothelioma - Pipeline Review, H1 2015

Pharma working capital leaves room for improvement

Pharmaceutical Marketing Disclosures

Global Non-Small Cell Lung Cancer Therapeutics Market

Rx-360 An International Pharmaceutical Supply Chain Consortium

Elenchi dei prodotti medicinali per le malattie rare in Europa*

FDA Office of Hematology and Oncology Products (OHOP) 2011 Review

Multiple Sclerosis Therapeutics to Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth

Marketing authorisations granted in March 2016

Review of the List of High-Cost Medicines used by the Dominican Republic s Protected Diseases Program and Planning of Purchases for 2015

Pain management for cancer patients Acute Ischemic Stroke. Hemophilia, Von willebrand disease & Bleeding disorders. Infectious Disease

Drug Formulary Update, July 2014 Commercial and State Programs

HIV 1. A reference guide for prescription HIV-1 medications

Antiretroviral Treatment Options for Patients on Directly Acting Antivirals for Hepatitis C. Daclatasvir (Daklinza, DCV, BMS )

Juli 2016 Verzeichnis der Arzneimittel für seltene Krankheiten in Europa*

The type 2 diabetes market is undergoing a paradigm

meeting report on the review of applications for orphan designation

May 2013 Declining Medicine Use and Costs: For Better or Worse?

Orphan drugs program. Discussion paper. May 2015

SPECIAL AUTHORIZATION GUIDELINES

Listes des médicaments pour les maladies rares en Europe*

Verzeichnis der Arzneimittel für seltene Krankheiten in Europa*

SMC Accepted Medicine Indication Formulary Decision To be used on Treatment of unresectable or metastatic, well- or everolimus (Afinitor) Novartis

THE ROYAL CORNWALL HOSPITALS NHS TRUST RESPONSE TO INFORMATION REQUEST. Date Request Received: 03 August 2015 FOI Ref: 947

Annex I. Article 31 of Directive 2001/83/EC. Procedure number: EMEA/H/A-31/1448

Product Profiles: Multiple Sclerosis - Gilenya Raises Bar for New Market Entrants

Fourth Quarter 2014 Provider Connection

Stakeholder Insight: Insulin Use in Type 2 Diabetes

Multiple Sclerosis. Current and Future Players. GDHC1009FPR/ Published March 2013

Global Peptide Therapeutics Market

M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends

CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS

Biopharmaceutical Raw Materials throughout the Product Lifecycle

REFERENCE CODE GDHC96PIDR PUBLICATION DATE APRIL 2015 PROSTATE CANCER GLOBAL DRUG FORECAST AND MARKET ANALYSIS TO 2023

Robert Ancuceanu for his exceptional work as he has resigned from the Committee and adopted the following opinions:

Global Pharmaceuticals Marketing Channel Reference EDITION

Specialty Pharmacy Program Drug List

Great-West s Drug Prior Authorization

Novel OAC s : How should we use them?

BioCentury IOBUSINESS. Buyside View XXI. Sunny side up

Key Findings. Use this report to... The Autoimmune Market Outlook to 2013

Commercial Perspectives: Multiple Sclerosis

The Pharmaceutical Industry in Figures

supplement 18 PAYS D'ORIGINE NOM DOSAGE FORME NR ST LABORATOIRE 4ML CONCENTRATE FOR SOLUTION FOR INFUSION x 1VIAL

Specialty Drug Program RX Benefit Member Guide

PAYS D'ORIGINE NOM DOSAGE FORME NR ST LABORATOIRE A-CNOTREN 20MG 30 SOFT CAPSULES /09 * GAP S.A FOR PHARMATHEN S.A GRECE ACUVAIL 0.

Transcription:

Final Belgian list: (Last update 07/12/2015) marketing name Active substance MAH Reason on list Monthly modifications: +/- 13 ADDITIONS - 1 RETRAIT ABASRIA INSULINE GLARGINE ELI LILLY REGIONAL OPERATIONS GMBH ACCOFIL FILGASTRIM ACCORD HEALTHCARE LIMITED ADCETRIS BRENTUXIMAB VEDOTINE TAKEDA GLOBAL R&D CENTRE (EUROPE) LTD, Cond Auth, ADEMPAS RIOCIGUAT BAYER PHARMA AKYNZEO NETUPITANT, PALONOSETRON HELSINN BIREX PHARMACEUTICALS LTD ALBUMEON HUMAN ALBUMIN? New biological ALDURAZYME LARONIDASE GENZYME EUROPE B.V. Auth under excep, AMITIZA LUBIPROSTON Sucampo Pharma Europe Ltd AMYVID FORBETAPIR (F-18) Q.S. ELI LILLY NEDERLAND BV ANORO GLAXO GROUP LTD UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE, APLEEK ETHINYL ESTRADIOL/GESTODENE BAYER PHARMA AG ATRIANCE NELARABINE 5.00 MG/ML GLAXO GROUP LTD Auth under excep ATRYN ANTITHROMBIN ALFA GTC BIOTHERAPEUTICS UK LIMITED Auth under excep, AUBAGIO TERIFLUNOMIDE SANOFI-AVENTIS GROUPE BELLINA CHLORMADINONE, ETHINYLESTRADIOL GEDEON RICHTER Plc Outcome Referral Art 31, BEMFOLA Follitropin alfa FINOX Biotech AG New biological BENLYSTA BELIMUMAB GLAXO GROUP LTD BETMIGA MIRABEGRON ASTELLAS PHARMA EUROPE B.V. BEXSERO NEISSERIA MENINGITIDES B, RECOMBINANT, COMPONENT, ADSORBED Q.S. NOVARTIS VACCINES & DIAGNOSTICS S.R.L. BLINCYTO BLINATUMOMAB AMGEN EUROPE BV, conditional auth + BOSULIF BOSUTINIB (MONOHYDRATE) 100.00 MG PFIZER LIMITED, Cond Auth, BRETARIS GENUAIR ACLIDINIUM BROMIDE ALMIRALL S.A, BRIMICA GENUAIR ACLIDINIUM BROMIDE/ FORMOTERL FUMARATE DIHYDRATE ALMIRALL S.A, BRINTELLIX VORTIOXETINE H. LUNDBECK A/S CAPRELSA VANDETANIB ASTRAZENECA AB, Cond Auth CEPLENE HISTAMINE DIHYDROCHLORIDE MEDA AB Auth under excep CERDELGA ELIGLUSTAT GENZYME EUROPE B.V., CHAMPIX VARENICLINE (TARTRATE) PFIZER LIMITED CINRYZE C1-INHIBITOR 500.00 IU VIROPHARMA BVBA CLAUDIA - 35 SANDOZ N.V. CLEVIPREX CLEVIDIPINE BUTYRATE THE MEDICINES COMPANY UK LTD CLUVOT HUMAN FACTOR VIII CSL BEHRING GmbH COMETRIQ CABOZANTINIB TMC Pharma Services Ltd, Cond Auth CONSTELLA LINACLOTIDE ALMIRALL S.A CONVULEX VALPROIC ACID TAKEDA BELGIUM CORLENTOR IVABRADINE SERVIER, LES LABORATOIRES COSENTYX SECUKINUMAB NOVARTIS EUROPHARM LIMITED COTELLIC COBIMETINIB ROCHE REGISTRATION LIMITED + CRESEMBA ISAVUCONAZOLE BASILEA MEDICAL LTD + CUPRYMINA COPPER (64-CU) CHLORIDE Q.S. SPARKLE S.R.L CYRAMZA RAMUCIRUMAB ELI LILLY NEDERLAND BV DACOGEN DECITABINE JANSSEN-CILAG INTERNATIONAL NV DAKLINZA DACLATASVIR BRISTOL MYERS SQUIBB/PFIZER EEIG

DALIRESP ROFLUMILAST 500.00 MCG NYCOMED GMBH DAPHNE MITHRA PHARMACEUTICALS S.A. DAXAS ROFLUMILAST NYCOMED GMBH DEFITELIO DEFIBROTIDE Gentium New biological, authorised under exceptional DELTYBA DELAMANID Otsuka Novel Products GmbH, Cond Auth DEPAKINE SODIUM VALPROATE SANOFI BELGIUM DEPAKINE CHRONO SODIUM VALPROATE, VALPROIC ACID SANOFI BELGIUM DEPAKINE CHRONO SODIUM VALPROATE, VALPROIC ACID PI-PHARMA NV DEPAKINE ENTERIC SODIUM VALPROATE SANOFI BELGIUM DEPAKINE IV SODIUM VALPROATE SANOFI BELGIUM DIANE-35 BAYER N.V. DIFICLIR FIDAXOMICIN ASTELLAS PHARMA EUROPE B.V. DOMPERIDON MYLAN DOMPERIDONE MALEATE MYLAN SPRL DOMPERIDON TEVA DOMPERIDONE MALEATE TEVA PHARMA BELGIUM N.V. DOMPERIDONE EG DOMPERIDONE MALEATE EUROGENERICS N.V. DOMPERIDONE INSTANT DOMPERIDONE EG EUROGENERICS N.V. DOMPERIDONE MYLAN DOMPERIDONE MALEATE MYLAN BVBA/SPRL DOMPERITOP DOMPERIDONE MALEATE APOTEX NV DUAKLIR GENUAIR ACLIDINIUM BROMIDE/ FORMOTERL FUMARATE DIHYDRATE ALMIRALL S.A EBYMECT DAPAGLIFLOZIN/METFORMIN ASTRAZENECA AB + EDARBI AZILSARTAN MEDOXOMIL (POTASSIUM) TAKEDA GLOBAL R&D CENTRE (EUROPE) LTD EDISTRIDE DAPAGLIFLOZIN ASTRAZENECA AB + EDURANT RILPIVIRINE (HYDROCHLORIDE) JANSSEN-CILAG INTERNATIONAL NV EKISTOL CILOSTAZOL??? Outcome Referral Art 31, EKLIRA GENUAIR ACLIDINIUM (BROMURE) ALMIRALL S.A., ELAPRASE IDURSULFASE SHIRE HUMAN GENETIC THERAPIES AB Auth under excep ELIQUIS APIXABAN BRISTOL MYERS SQUIBB/PFIZER EEIG ELISAMYLAN 35 MYLAN BVBA/SPRL ELOCTA EFMOROCTOCOG ALFA BIOGEN IDEC LTD + ELVANSE / TYVENSE LISDEXAMPHETAMINE BRYSTOL MYERS SQUIBB/ PFIZER EEIG ENTRESTO SACUBITRIL/ VALSARTAN NOVARTIS EUROPHARM LIMITED + ENTYVIO VEDOLIZUMAB TAKEDA PHARMA A/S ENUREV BREEZHALER GLYCOPYRRONIUM (BROMIDE) NOVARTIS EUROPHARM LIMITED, EPERZAN ALBIGLUTIDE GlaxoSmithKline Trading Services Limited ERIVEDGE VISMODEGIB ROCHE REGISTRATION LIMITED, Cond Auth ESBRIET PIRFENIDONE INTERMUNE EUROPE LTD, EURARTESIM PIPERAQUINE TETRAPHOSPHATE (TETRAHYDRATE), DIHYDROARTEMISININ (DHA) SIGMA-TAU INDUSTRIE FARMAC. RIUNITE SPA, EVARREST FIBRINOGEN, HUMAN Q.S., THROMBIN, HUMAN Q.S. OMRIX BIOPHARMACEUTICALS N.V. EVIPLERA ENOFOVIR DISOPROXIL (FUMARATE), EMTRICITABINE GILEAD SCIENCES LTD, RILPIVIRINE (HYDROCHLORIDE) EVOLTRA CLOFARABINE GENZYME EUROPE B.V. Auth under excep EVOTAZ ATAZANAVIR/COBICISTAT Bristol-Myers Squibb Pharma Eeig

EXJADE DEFERASIROX NOVARTIS EUROPHARM LIMITED EXVIERA DASABUVIR ABBVIE LTD EYLEA AFLIBERCEPT BAYER AG EZICLEN SULPHATE ANHYDROUS, MAGNESIUM SULFATE HEPTAHYDRATE, POTASSIUM SULPHATE IPSEN PHARMA FAMPYRA FAMPRIDINE BIOGEN IDEC LTD, Cond Auth FARYDAK Panobinostat Novartis Europharm limited FERTINORM KIT Gonadotrophin Postmenopausal (HMG) Non Numerical Laboratoires Amount quantum Genévrier satis SA FEXERIC FERRIC CITRATE COORDINATION COMPLEX KERYX BIOPHARMA UK LTD, FIRDAPSE AMIFAMPRIDINE (PHOSPHATE) BIOMARIN EUROPE LTD Auth under excep, FLUENZ INFLUENZA VIRUS, LIVE, ATTENUATED Q.S. MEDIMMUNE LLC FLUENZ TETRA INFLUENZA VIRUS (LIVE, ATTENUATED Q.S., NASAL) MEDIMMUNE LLC FORXIGA DAPAGLIFLOZIN (PROPANEDIOL MONOHYDRATE) BRISTOL MYERS SQUIBB/ASTRAZENECA EEIG FYCOMPA PERAMPANEL EISAI EUROPE LTD GAZYVARO OBINUTUZUMAB ROCHE REGISTRATION LIMITED GENVOYA ELVITEGRAVIR/ COBICISTAT/ EMTRICITABINE/ TENOFOVIR ALAFENAMIDE GILEAD SCIENCES LTD + GEONISTIN OXYTETRACYCLIN, NYSTATIN Pliva Hrvatska d.o.o. GILENYA FINGOLIMOD (HYDROCHLORIDE) 0.50 MG NOVARTIS EUROPHARM LIMITED, GIOTRIF AFATINIB Boehringer Ingelheim International GLIVEC IMATINIB NOVARTIS EUROPHARM LIMITED GLYBERA ALIPOGENE TIPARVOVEC Q.S. UNIQURE BIOPHARMA B.V, Auth under excep, GRASTOFIL FILGASTRIM Apotex Europe GRATIELLA 35 3DDD PHARMA N.V. HAES-STERIL 6% HYDROXYETHYL STARCH FRESENIUS KABI NV Outcome Referral Art 31, HAES-STERIL 10% HYDROXYETHYL STARCH FRESENIUS KABI NV Outcome Referral Art 31, HALAVEN ERIBULIN (MESYLATE) 0.44 MG/ML EISAI LIMITED HARVONI LEDIPASVIR, SOFOSBUVIR GILEAD SCIENCES LTD HELEN CHLORMADINONE, ETHINYLESTRADIOL Mithra Pharmaceuticals S.A. Outcome Referral Art 31, HETLIOZ TASIMELTEON Vanda Pharmaceuticals Limited Ltd HEXACIMA Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rdna), poliomyelitis (inactivated) and Haemophilus influenzae type B conjugate vaccine SANOFI PASTEUR SA (adsorbed) HEXYON Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rdna), poliomyelitis (inactivated) and Haemophilus influenzae type B conjugate vaccine (adsorbed) SANOFI PASTEUR MSD HIZENTRA IMMUNOGLOBULIN HUMAN NORMAL 200.00 MG/ML BIOCLS GMBH HOLOCLAR EX VIVO EXPENDED AUTOLOGOUS HUMAN CORNEAL EPITHELIAL CELLS CONTAINING STEM CELLS CHIESI FARMACEUTICI SPA, Cond Auth HYQVIA IMMUNOGLOBULIN HUMAN NORMAL 100.00 MG/ML BAXTER INNOVATIONS GMBH ICLUSIG PONATINIB (HYDROCHLORIDE) ARIAD PHARMA LTD

ILARIS CANAKINUMAB NOVARTIS EUROPHARM LIMITED Auth under excep, IMBRUVICA IBRUTINIB JANSSEN-CILAG INTERNATIONAL NV IMNOVID (POMALIDOMIDE POMALIDOMIDE CELGENE EUROPE LIMITED, CELGENE) IMVANEX Modified Vaccinia Ankara virus - Bavarian Nordic, Auth under excep BAVARIAN NORDIC A/S (MVA-BN) live virus INCIVO TELAPREVIR JANSSEN-CILAG INTERNATIONAL NV INCRELEX MECASERMIN IPSEN PHARMA Auth under excep, INCRESYNC ALOGLIPTIN/PIOGLITAZONE TAKEDA PHARMA A/S INCRUSE UMECLIDINIUM BROMIDE Glaxo Group Ltd INFLECTRA INFLIXIMAB HOSPIRA UK LTD INFLUSPLIT/ FLUARIX TETRA Influenza virus inactivated split virion GLAXO GROUP LTD Biological INLYTA AXITINIB PFIZER LIMITED INTUNIV Guanfacine SHIRE PHARMACEUTICAL CONTRACTS LTD INVOKANA CANAGLIFLOZIN JANSSEN-CILAG INTERNATIONAL NV IPREZIV AZILSARTAN MEDOXOMIL (POTASSIUM) TAKEDA GLOBAL R&D CENTRE (EUROPE) LTD IVABRADINE ANPHARM IVABRADINE ANPHARM Przedsiębiorstwo Farmaceutyczne S.A. JAKAVI RUXOLITINIB (PHOSPHATE) NOVARTIS EUROPHARM LIMITED, JARDIANCE EMPAGLIFLOZIN BOEHRINGER INGELHEIM INTERNATIONAL GMBH JAYDESS LEVONORGESTREL 13.50 MG BAYER N.V. JENTADUETO METFORMIN HYDROCHLORIDE, LINAGLIPTIN BOEHRINGER INGELHEIM INTERNATIONAL GMBH JETREA OCRIPLASMIN THROMBOGENICS NV JEVTANA CABAZITAXEL SANOFI-AVENTIS GROUPE JINARC TOLVAPTAN Otsuka Pharmaceutical Europe Ltd KADCYLA TRASTUZUMAB EMTANSINE ROCHE REGISTRATION LIMITED KALYDECO IVACAFTOR VERTEX PHARMACEUTICALS LIMIT, KANUMA SEBELIPASE ALFA Synageva BioPharma Ltd, KENGREXAL CANGRELOR The Medicines Company UK Ltd KETOCONAZOLE HRA KETOCONAZOLE LABORATOIRE HRA PHARMA KEYTRUDA PEMBROLIZUMAB Merck Sharp & Dohme Ltd KOLBAM CHOLIC ACID FGK REPRESENTATIVE SERVICE GMBH Auth under excep KRYSTEXXA PEGLOTICASE SAVIENT PHARMA IRELAND LIMITED, KYPROLIS CARFILZOMIB AMGEN EUROPE BV + LACTEST GASILOXE Lactest S.L. / Venter Pharma S.L. LATUDA LURASIDONE TAKEDA PHARMA A/S LAVENTAIR UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE GLAXO GROUP LTD, LEMTRADA ALEMTUZUMAB GENZYME THERAPEUTICS LTD LIBERTEK ROFLUMILAST NYCOMED GMBH LOJUXTA LOMITAPIDE (MESYLATE) AEGERION PHARMACEUTICALS, Auth under excep LONQUEX LIPEGFILGRASTIM TEVA PHARMA BV, LYMPHOSEEK TILMANOCEPT NAVIDEA BIOPHARMACEUTICALS LIMITED LTD LYNPARZA OLAPARIB ASTRAZENECA AB

LYXUMIA LIXISENATIDE SANOFI-AVENTIS GROUPE MACI CHONDROCYTES, AUTOLOGOUS CULTURED Q.S. GENZYME EUROPE B.V. MEKINIST TRAMETINIB GLAXO GROUP LTD MERIOFERT MENOTROPHIN LABORATOIRE GENEVRIER SA MOTILIUM DOMPERIDONE MALEATE JOHNSON & JOHNSON CONSUMER N.V. MOTILIUM DOMPERIDONE JOHNSON & JOHNSON CONSUMER N.V. MOTILIUM DOMPERIDONE PI-PHARMA NV MOTILIUM DOMPERIDONE IMPEXECO SA MOVENTIG NALOXEGOL ASTRAZENECA AG MYSIMBA NALTREXONE, BUPROPION OREXIGEN THERAPEUTICS IRELAND LIMITED NAGLAZYME GALSULFASE BIOMARIN EUROPE LTD Auth under excep, NEURACEQ FLORBETABEN (18F) Piramal Imaging GmbH PROTEOLYTIC ENZYMES (CONCENTRATE) ENRICHED IN NEXOBRID MEDIWOUND GERMANY, BROMELAIN NIMENRIX NEISSERIA MENINGITIDES A+C+W+Y, POLYSACCHARIDE CONJ. TO TETANUS TOXOID Q.S. GLAXOSMITHKLINE BIOLOGICALS S.A., NIVOLUMAB BMS NIVOLUMAB BRISTOL-MYERS SQUIBB PHARMA EEIG NOVOEIGHT Turoctocog alfa NOVO NORDISK A/S NOVOTHIRTEEN CATRIDECACOG NOVO NORDISK A/S NULOJIX BELATACEPT BRISTOL-MYERS SQUIBB PHARMA EEIG NUMETZAH G16%E alanine, arginine, aspartic acid, calcium chloride, cysteine, glucose monohydrate, glutamic acid, glycine, histidine, isoleucine, leucine, lysine monohydrate, magnesium acetate, methionine, olive oil, ornithine BAXTER S.A. hydrochloride, henylalanine, potassium acetate, proline, serine, sodium chloride, sodium glycerophosphate, soybean oil, taurine, threonine, tryptophan, tyrosine, valine Outcome Referral Art 31, NUWIQ SIMOCTOCOG ALFA OCTAPHARMA AB OBIZUR SUSOCTOCOG ALFA BAXALTA INNOVATIONS GMBH, authorised under excep ODOMZO SONIDEGIB NOVARTIS EUROPHARM LIMITED OFEV NINTEDANIB BOEHRINGER INGELHEIM INTERNATIONAL GMBH OLYSIO SIMEPREVIR JANSSEN-CILAG INTERNATIONAL NV OPGENRA EPTOTERMIN ALFA OLYMPUS BIOTECH LTD OPSUMIT MACITENTAN Actelion Registration Ltd OPTIMARK GADOVERSETAMIDE MALLINCKRODT MEDICAL GMBH ORBACTIV ORITAVANCIN THE MEDICINES COMPANY UK LTD ORKAMBI LUMACAFTOR/ IVACAFTOR VERTEX PHARMACEUTICALS LIMIT + OROPERIDYS DOMPERIDONE PIERRE FABRE MEDICAMENT ORPHACOL CHOLIC ACID LABORATOIRES CTRS Auth under excep OSSEOR STRONTIUM RANELATE SERVIER, LES LABORATOIRES OTEZLA APREMILAST CELGENE EUROPE LIMITED OVALEAP FOLLITROPIN ALPHA TEVA PHARMA GMBH PANDEMRIX INFLUENZA VIRUS (INACTIVATED) Q.S. GLAXOSMITHKLINE BIOLOGICALS S.A. PERJETA PERTUZUMAB ROCHE REGISTRATION LIMITED PICATO INGENOL MEBUTATE LEO PHARMA A/S +

PIXUVRI PIXANTRONE (DIMALEATE) CTI LIFE SCIENCES LTD, Cond Auth PLASMAVOLUME REDIBAG 6% HYDROXYETHYL STARCH BAXTER S.A. Outcome Referral Art 31, PLEGRIDY PEGINTERFERON BETA-1A BIOGEN IDEC LTD PLETAL CILOSTAZOL??? Outcome Referral Art 31, PRALUENT ALIROCUMAB SANOFI-AVENTIS GROUPE PRAXBIND IDARUCIZUMAB BOEHRINGER INGELHEIM INTERNATIONAL GMBH + PROCORALAN IVABRADINE SERVIER, LES LABORATOIRES PROTELOS STRONTIUM RANELATE SERVIER, LES LABORATOIRES QUINSAIR LEVOFLOXACIN Aptalis Pharma SAS RAPLIXA HUMAN FIBRINOGEN, HUMAN THROMBIN PROFIBRIX BV RAXONE IDEBENONE SANTHERA PHARMACEUTICALS ( Deutschland) GmbhAuth under excep RELVAR ELLIPTA FLUTICASONE FUROATE: VILANTEROL TRIFENATATE GLAXO GROUP LTD, REMSIMA INFLIXIMAB CELLTRION HEALTHCARE HUNGARY KFT. REPATHA EVOLOCUMAB AMGEN EUROPE BV RESPREEZA HUMAN ALFA-1 PROTEINASE INHIBITOR CSL BEHRING GmbH REVESTIVE TEDUGLUTIDE NYCOMED DANMARK APS, REVLIMID LENALIDOMIDE CELGENE EUROPE LIMITED REVINTY ELLIPTA FLUTICASONE FUROATE: VILANTEROL TRIFENATATE GLAXO GROUP LTD REZOLSTA DARUNAVIR/COBICISTAT JANSSEN-CILAG INTERNATIONAL NV RISTEMPA PEGFILGRASTIM AMGEN EUROPE BV RIXUBIS NONACOG GAMMA BAXTER INNOVATIONS GMBH RYZODEG INSULIN ASPART 30.00 UML, INSULIN DEGLUDEC 70.00 UML NOVO NORDISK A/S SAXENDA LIRAGLUTIDE NOVO NORDISK A/S SCENESSE AFAMELANOTIDE CLINUVEL UK LIMITED, Auth under excep SEASONIQUE LEVONORGESTREL, ETHINYLESTRADIOL TEVA PHARMA BELGIUM N.V.? + SEEBRI BREEZHALER GLYCOPYRRONIUM (BROMIDE) NOVARTIS EUROPHARM LIMITED, SELINCRO NALMEFENE (HYDROCHLORIDE DIHYDRATE) LUNDBECK A/S SENSHIO OSPEMIFENE SHIONOGI LIMITED New as, SIGNIFOR PASIREOTIDE (DIASPARTATE) NOVARTIS EUROPHARM LIMITED SIRTURO BEDAQUILINE JANSSEN-CILAG INTERNATIONAL NV, conditional auth SIVEXTRO TEDIZOLID PHOSPHATE CUBIST UK LTD SOMATROPIN BIOPARTNERS SOMATROPIN BIOPARTNERS SOVALDI SOFOSBUVIR GILEAD SCIENCES INTERNATIONAL LTD SPEDRA AVANAFIL VIVUS BV STIVARGA REGORAFENIB BAYER AG STRENSIQ ASFOTASE ALFA ALEXION EUROPE SAS, Aut under excep STRIBILD TENOFOVIR DISOPROXIL (FUMARATE), EMTRICITABINE, ELVITEGRAVIR, COBICISTAT GILEAD SCIENCES LTD STRIVERDI RESPIMAT OLODATEROL BOEHRINGER INGELHEIM INTERNATIONAL GMBH, SYLVANT SILTUXIMAB JANSSEN-CILAG INTERNATIONAL NV TAFINLAR DABRAFENIB GLAXOSMITHKLINE TRADING SERVICES LIMITED

TARGOCID ACIPIMOX PFIZER 0 TETRASPAN 6% HYDROXYETHYL STARCH B. BRAUN MELSUNGEN AG Outcome Referral Art 31, TETRASPAN 10% HYDROXYETHYL STARCH B. BRAUN MELSUNGEN AG Outcome Referral Art 31, TEYSUNO TEGAFUR, GIMERACIL, OTERACIL (MONOPOTASSIUM) NORDIC GROUP BV, THIOSIX TIOGUANIN TEVA NEDERLAND B.V. Auth under excep TIVICAY DOLUTEGRAVIR ViiV Healthcare UK Limited TOVANOR BREEZHALER GLYCOPYRRONIUM (BROMIDE) NOVARTIS EUROPHARM LIMITED, TRAJENTA LINAGLIPTIN BOEHRINGER INGELHEIM INTERNATIONAL GMBH TRANSLARNA ATALUREN PTC Therapeutics Limited, conditional auth TRESIBA INSULIN DEGLUDEC NOVO NORDISK A/S TRIUMEQ DOLUTEGRAVIR, ABACAVIR, LAMIVUDINE VIIV HEALTHCARE UK Ltd TROBALT RETIGABINE GLAXO GROUP LTD TYBOST COBICISTAT Gilead Sciences TYGACIL TIGECYCLINE PFIZER LIMITED TYSABRI NATALIZUMAB BIOGEN IDEC LTD ULTIBRO BREEZHALER INDACATEROL (MALEATE), GLYCOPYRRONIUM (BROMIDE) NOVARTIS EUROPHARM LIMITED ULUNAR BREEZHALER INDACATEROL (MALEATE), GLYCOPYRRONIUM (BROMIDE) NOVARTIS EUROPHARM LIMITED UNITUXUN DINUTUXIMAB UNITED THERAPEUTICS EUROPE LTD, VALPROATE MYLAN SODIUM VALPROATE MYLAN BVBA VALPROATE RETARD EG SODIUM VALPROATE, VALPROIC ACID EG VALPROATE RETARD MYLAN SODIUM VALPROATE MYLAN BVBA VALPROATE SANDOZ SODIUM VALPROATE, VALPROIC ACID SANDOZ NV VEDROP TOCOPHEROL D-ALPHA (AS TOCOFERSOLAN) ORPHAN EUROPE SARL Auth under excep, VELPHORO Mixture of polynuclear iron(iii)-oxyhydroxide, sucrose Vifor Fresenius Medical Care Renal Pharma France and starches VENOFER IRON SUCROSE Vifor France VENOHES 6% HYDROXYETHYL STARCH B. BRAUN MELSUNGEN AG Outcome Referral Art 31, VEPACEL INFLUENZA VIRUS (INACTIVATED) Q.S. BAXTER INNOVATIONS GMBH VIBATIV TELAVANCIN Clinigen Healthcare Limited VICTRELIS BOCEPREVIR MERCK SHARP & DOHME LTD VIEKIRAX OMBITASVIR, PARITAPREVIR, RITONAVIR ABBVIE LTD VIMIZIM ELOSULFASE ALFA BIOMARIN EUROPE LTD, VIPDOMET ALOGLYPTIN / METFORMIN TAKEDA PHARMA A/S VIPIDIA ALOGLYPTIN TAKEDA PHARMA A/S VITEKTA ELVITEGRAVIR Gilead Sciences International Ltd VIZAMYL FLUTEMETAMOL (18F) GE Healthcare Ltd VOKANAMET CANAGLIFLOZIN / METFORMIN HYDROCHLORIDE JANSSEN-CILAG INTERNATIONAL NV VOLULYTE 6% HYDROXYETHYL STARCH FRESENIUS KABI NV Outcome Referral Art 31, VOLUVEN 6% HYDROXYETHYL STARCH FRESENIUS KABI NV Outcome Referral Art 31, VOLUVEN 10% HYDROXYETHYL STARCH FRESENIUS KABI NV Outcome Referral Art 31, VONCENTO FACTOR VIII HUMAN 1000.00 IU, FACTOR VON WILLEBRAND 2400.00 IU TEVA PHARMA BV VOTUBIA EVEROLIMUS NOVARTIS EUROPHARM LIMITED Conditional auth -

VYNDAQEL TAFAMIDIS (MEGLUMINE) PFIZER LIMITED Auth under excep, New AS, XADAGO SAFINAMIDE Zambon Group SpA XAGRID XAGRID SHIRE PHARMACEUTICAL CONTRACTS LTD Auth under excep XALKORI CRIZOTINIB PFIZER LIMITED, Cond Auth XARELTO RIVAROXABAN 10.00 MG BAYER SCHERING PHARMA AG XGEVA DENOSUMAB AMGEN EUROPE BV New biological XIAPEX COLLAGENASE CLOSTRIDIUM HISTOLYTICUM AUXILIUM UK LIMITED XIGDUO DAPAGLIFLOZIN/METFORMIN BRISTOL MYERS SQUIBB/PFIZER EEIG XOFIGO Radium Ra 223 dichloride Bayer Pharma AG XOTERNA BREEZHALER INDACATEROL / GLYCOPYRRONIUM TEVA PHARMA BV XTANDI ENZALUTAMIDE ASTELLAS PHARMA EUROPE B.V. XULTOPHY INSULIN DEGLUDEC, LIRAGLUTIDE NOVO NORDISK A/S XYDALBA DALBAVANCIN DURATA THERAPEUTICS INTERNATIONAL bv YELLOX BROMFENAC (SODIUM SESQUIHYDRATE) CROMA-PHARMA GMBH YERVOY IPILIMUMAB BRISTOL-MYERS SQUIBB PHARMA EEIG, YONDELIS TRABECTEDIN PHARMA MAR SA Auth under excep ZALTRAP AFLIBERCEPT SANOFI-AVENTIS GROUPE ZELBORAF VEMURAFENIB ROCHE REGISTRATION LIMITED ZERBAXA CEFTOLOZANE/ TAZOBACTAM MERCK SHARP & DOHME LTD ZILIUM DOMPERIDONE MALEATE KELA PHARMA NV ZINFORO CEFTAROLINE FOSAMIL (ACETIC ACID SOLVATE MONOHYDRATE) ASTRAZENECA AB ZOELY THERAMEX S.r.l. NOMOGESTROL ACETATE / ESTRADIOL HEMIHYDRATE ZONTIVITY VORAPAXAR MERCK SHARP & DOHME LTD ZYDELIG IDELALISIB GILEAD SCIENCES INTERNATIONAL LTD ZYKADIA CERITINIB NOVARTIS EUROPHARM LIMITED, Cond Auth ZYTIGA ABIRATERONE ACETATE JANSSEN-CILAG INTERNATIONAL NV NOTE In Red in Black in blue in grey Conditional auth commercialised / commercialisé / gecommercialiseerd not commercialised / pas commercialisé / niet gecommercialiseerd info not yet available / info non disponible / info niet beschikbaar New addition of this month / nouvelle addition de ce mois / nieuwe toevoeging van deze maand nouvelle substance active / nieuw actief bestanddeel nouveau médicament biologique / nieuwe biologische geneesmiddel Etude de sécurité post-autorisation / post-autorisatie veiligheidsstudies Autorisé sous certaines conditions / vergund onder bepaalde voorwaarden

Auth under excep autorisé sous circonstances exceptionnelles / vergund onder uitzonderlijke omstandigheden Product informations / informations sur les produits / produkten informaties informations sur les produits/productinformatie http://www.fagg-afmps.be/search?language=fr&search_field=notice